In the last trading session, 0.17 million Apogee Therapeutics Inc (NASDAQ:APGE) shares changed hands as the company’s beta touched 2.28. With the company’s per share price at $46.51 changed hands at -$0.99 or -2.08% during last session, the market valuation stood at $2.77B. APGE’s last price was a discount, traded about -55.43% off its 52-week high of $72.29. The share price had its 52-week low at $27.05, which suggests the last value was 41.84% up since then. When we look at Apogee Therapeutics Inc’s average trading volume, we note the 10-day average is 0.61 million shares, with the 3-month average coming to 452.29K.
Apogee Therapeutics Inc (NASDAQ:APGE) trade information
Instantly APGE was in red as seen at the end of in last trading. With action -1.60%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 69.36%, with the 5-day performance at -1.60% in the red. However, in the 30-day time frame, Apogee Therapeutics Inc (NASDAQ:APGE) is 8.88% up. Looking at the short shares, we see there were 7.36 million shares sold at short interest cover period of 16.72 days.
The consensus price target for the stock as assigned by Wall Street analysts is 95, meaning bulls need an upside of 51.04% from its current market value. According to analyst projections, APGE’s forecast low is 95 with 95 as the target high. To hit the forecast high, the stock’s price needs a -104.26% plunge from its current level, while the stock would need to soar -104.26% for it to hit the projected low.
Apogee Therapeutics Inc (APGE) estimates and forecasts
Data shows that the Apogee Therapeutics Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 23.71% over the past 6 months, a 8.04% in annual growth rate that is considerably lower than the industry average of 16.70%.
The 2024 estimates are for Apogee Therapeutics Inc earnings to increase by 7.87%.
APGE Dividends
Apogee Therapeutics Inc is expected to release its next quarterly earnings report in January.
Apogee Therapeutics Inc (NASDAQ:APGE)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 11.70% of Apogee Therapeutics Inc shares while 127.15% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 144.00%.
